EXHIBIT 31.1


CERTIFICATION

I, MAO Peng, certify that:

1.  I  have   reviewed   this   quarterly   report  on  Form   10-QSB  of  China
Biopharmaceuticals Holdings, Inc.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
Company as of, and for, the periods presented in this quarterly report;

4. The Company's other certifying officer and I are responsible for establishing
and maintaining  disclosure  controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d 15(e) for the Company and we have:

         i.       designed such disclosure  controls and  procedures,  or caused
                  such  disclosure  controls or procedures to be designed  under
                  our supervision,  to ensure that material information relating
                  to the Company,  including its consolidated  subsidiaries,  is
                  made known to us by others within those entities, particularly
                  during  the  period in which  this  quarterly  report is being
                  prepared;

         ii.      evaluated  the  effectiveness  of  the  Company's   disclosure
                  controls  and  procedures  and  presented  in this  report our
                  conclusions about the effectiveness of the disclosure controls
                  and  procedures,  as of the end of the period  covered by this
                  report based on such evaluation;

         iii.     disclosed in this report any change in the Company's  internal
                  control over  financial  reporting  that  occurred  during the
                  Company's  most  recent  fiscal  quarter  that has  materially
                  affected,  or is reasonably likely to materially  affect,  the
                  Company's internal control over financial reporting.

5. The Company's other  certifying  officer and I have  disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
Company's  auditors and the audit  committee of Company's board of directors (or
persons performing the equivalent function):

         i.       all significant  deficiencies  and material  weaknesses in the
                  design  or  operation  of  internal   control  over  financial
                  reporting which are reasonably  likely to adversely affect the
                  Company's  ability to record,  process,  summarize  and report
                  financial information; and

         ii.      any fraud,  whether or not material,  that involves management
                  or  other  employees  who  have  a  significant  role  in  the
                  Company's internal control over financial reporting.

Date: February 4, 2005

/s/ MAO Peng
------------------------------------
MAO Peng
Chairman and Chief Executive Officer